Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$4.06 USD
-0.11 (-2.64%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $4.06 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/25/25 |
---|---|
Current Quarter | -0.28 |
EPS Last Quarter | -0.35 |
Last EPS Surprise | 12.50% |
ABR | 2.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.16 |
Next Year | -1.08 |
EPS (TTM) | -0.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 80.00M | NA |
# of Estimates | NA | NA | 3 | NA |
High Estimate | NA | NA | 80.00M | NA |
Low Estimate | NA | NA | 80.00M | NA |
Year ago Sales | 0.87M | 0.00M | 2.81M | 80.00M |
Year over Year Growth Est. | NA | NA | 2,752.05% | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.28 | -0.26 | -0.16 | -1.08 |
# of Estimates | 5 | 3 | 5 | 5 |
Most Recent Consensus | -0.27 | -0.26 | -0.15 | -0.97 |
High Estimate | -0.23 | -0.22 | -0.08 | -0.81 |
Low Estimate | -0.34 | -0.30 | -0.23 | -1.51 |
Year ago EPS | -0.40 | -0.43 | -1.59 | -0.16 |
Year over Year Growth Est. | 30.00% | 39.53% | 89.94% | -578.75% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.28 | -0.26 | -0.16 | -1.08 |
7 Days Ago | -0.28 | -0.25 | -0.16 | -1.05 |
30 Days Ago | -0.28 | -0.25 | -0.16 | -1.05 |
60 Days Ago | -0.29 | -0.25 | -0.18 | -1.07 |
90 Days Ago | -0.32 | -0.28 | -0.27 | -1.14 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.28 | -0.26 | -0.16 | -1.08 |
Zacks Consensus Estimate | -0.28 | -0.26 | -0.16 | -1.08 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.35 | 0.87 | -0.43 | -0.40 | NA |
Estimate | -0.40 | -0.06 | -0.44 | -0.44 | NA |
Difference | 0.05 | 0.93 | 0.01 | 0.04 | 0.26 |
Surprise | 12.50% | 1,550.00% | 2.27% | 9.09% | 393.47% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more